EFFECT OF THE ASSOCIATION OF AMANTADINE AND QUETIAPINE IN THE TREATMENT OF REM SLEEP BEHAVIOR DISORDER: CASE REPORT
DOI:
https://doi.org/10.25110/arqsaude.v27i8.2023-007Palavras-chave:
REM Sleep, Amantadine, Behavioral Disorder, QuetiapineResumo
The aim was to report the case of a patient with REM sleep behavior disorder, unresponsive to standard treatment and with complete control of the condition after association of amantadine. Female patient, 45 years old, with systemic arterial hypertension and hypothyroidism, referred to neurological care, reporting frequent episodes of nocturnal agitation in the first hours of sleep, with walking and vocalization, waking up easily if called. She complains of drowsiness and anxiety, secondary to the impact of the RBD on her personal life. She mentions previous attempts at drug treatment with benzodiazepines (Bromazepam and Clonazepam), Zolpidem and Trazodone, all without clinical improvement, with Quetiapine being introduced at a low dose (not yet tried) 25mg, with a therapeutic target of 50mg with partial improvement only with 25mg. When trying 50mg, presenting a worsening of the picture. In a new follow-up, therapy with Amantadine 50 mg/day associated with Quetiapine 25 mg/day was started. The patient returned reporting a significant improvement in the condition, less frequent episodes associated with reduced nocturnal movement. After adaptation of the combined therapy, with adjustments in the dose of Amantadine, an increase of 50mg every 14 days up to 200 mg/day, with the possibility of using quetiapine 50mg (balance between the drugs), the patient evolved stable, with a great improvement in the quality of life and absence of new episodes of the sleep disorder.
Referências
Aurora RN, Zak RS, Maganti RK, Auerbach SH, Casey KR, Chowdhuri S et al. Best Practice Guide for the Treatment of REM Sleep Behavior Disorder (RBD). J Clin Sleep Med 2010; 6: 85.
Boeve BF, Silber MH, Ferman TJ, Lucas JA, Parisi JE. Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy. Movement disorders: official journal of the Movement Disorder Society. 2001 Jul;16(4):622-30.
Boeve BF, Silber MH, Ferman TJ. REM sleep behavior disorder in Parkinson’s disease and dementia with Lewy bodies. J Geriatr Psychiatry Neurol 2004; 17: 146–157.
Boeve BF, Silber MH, Saper CB, Ferman TJ, Dickson DW, Parisi JE et al. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain 2007; 130: 2770–2788.
Boeve BF. REM sleep behavior disorder: Updated review of the core features, the REM sleep behavior disorder-neurodegenerative disease association, evolving concepts, controversies, and future directions. Ann N Y Acad Sci 2010; 1184: 15–54.
Boeve BF, Silber MH, Ferman TJ, et al. Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder. Sleep Med 2013; 14(8): 754 – 762.
Bonakis A, Howard RS, Williams A. Narcolepsy presenting as REM sleep behaviour disorder. Clin Neurol Neurosurg 2008; 110: 518–520.
Carley DW, Farabi SS. Physiology of Sleep. Diabetes Spectr 2016;29(1):5-9.
Chroverty S. Overview of sleep & sleep disorders. Indian J Med Res. 2010;131:126-40.
Fraigne JJ, Torontali ZA, Snow MB, Peever JH. REM Sleep at its Core - Circuits, Neurotransmitters, and Pathophysiology. Front Neurol. 2015 May 29 (6): 1-9.
Gagnon JF, Bédard MA, Fantini ML, Petit D, Panisset M, Rompré S et al. REM sleep behavior disorder and REM sleep without atonia in Parkinson’s disease. Neurology 2002; 59: 585–589.
Gagnon JF, Bédard MA, Fantini ML, Petit D, Panisset M, Rompre S, Carrier J, Montplaisir J. REM sleep behavior disorder and REM sleep without atonia in Parkinson’s disease. Neurology. 2002 Aug 27;59(4):585-9.
Gjerstad MD, Boeve B, Wentzel-Larsen T, Aarsland D, Larsen JP. Occurrence and clinical correlates of REM sleep behaviour disorder in patients with Parkinson’s disease over time. Journal of Neurology, Neurosurgery & Psychiatry. 2008 Apr 1;79(4):387-91.
Heather MM, Ross DZ. Amantadine and memantine: a comprehensive review for acquired brain injury. Brain Injury. 2020, Jan 34:3: 299-315.
Howell M, Alon; Avidan Y, Foldvary-Schaefer N, Malkani RG, During EH et al. Management of REM sleep behavior disorder: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment. Journal of Clinical Sleep Medicine 2022.
Howell M, Alon ;, Avidan Y, Foldvary-Schaefer N, Malkani RG, During EH et al. Management of REM sleep behavior disorder: an American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine 2022.
Iranzo A, Molinuevo JL, Santamaría J, Serradell M, Martí MJ, Valldeoriola F, Tolosa E. Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol. 2006 Jul;5(7):572-7.
Krystal AD, Sorscher AJ. Recognizing and managing insomnia in primary care and specialty settings. J Clin Psychiatry 2016;77(4):e471.
Lena I, Parrot S, Deschaux O, Muffat-Joly S, Sauvinet V, Renaud B, et al. Variations in extracellular levels of dopamine, noradrenaline, glutamate, and aspartate across the sleep – wake cycle in the medial prefrontal cortex and nucleus accumbens of freely moving rats. J Neurosci Res (2005) 81:891–9.
Loggini A, Tangonan R, Ammar FE, Mansour A, Goldenberg FD, Kramer CL, Lazaridis C. The role of amantadine in cognitive recovery early after traumatic brain injury: A systematic review. Clinical Neurology and Neurosurgery. 2020, Jul, 194: 105815.
Mahowald MW, Shenck CH, Cramer Bornemann MA. Pathophysiologic mechanisms in REM sleep behavior disorder. Curr Neurol Neurosci Rep 2007; 7: 167–172.
Miglis MG, Adler CH, Antelmi E, Arnaldi D, Baldelli L, Boeve BF et al. Biomarkers of conversion to α-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorder. Lancet Neurol 2021; 20: 671–684.
Neves GSML, Giorelli AS, Florido P, Gomes MM. Transtornos do sono: visão geral. Rev Bras Neurol. 2013;49(2):57-71.
Nightingale S, Orgill JC, Ebrahim IO, de Lacy SF, Agrawal S, Williams AJ. The association between narcolepsy and REM behavior disorder (RBD). Sleep Med 2005; 6: 253–258.
Olson EJ, Boeve BF, Silber MH. Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases. Brain. 2000 Feb;123 ( Pt 2):331-9.
Plazzi G, Corsini R, Provini F, Pierangeli G, Martinelli P, Montagna P et al. REM sleep behavior disorders in multiple system atrophy. Neurology 1997; 48: 1094–1096.
Postuma RB, Gagnon JF, Vendette M, Fantini ML, Massicotte-Marquez J, Montplaisir J. Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology. 2009 Apr 14;72(15):1296-300.
Raupp-Barcaro FM, Dias ICS, Meyer E, Vieira JCF, Pereira GS, Petkowicz AR, Oliveira MW, Andreatini R. Involvement of dopamine D2 and glutamate NMDA receptors in the antidepressant-lik effect of amantadine in mice. Behavioural Brain Research. 2021, Sep 413 (10): 113443.
Raupp-Barcaro IF, Vital MA, Galduróz JC, Andreatini R. Potential antidepressant effect of amantadine: a review of preclinical studies and clinical trials. Braz J Psychiatry. 2018 Oct-Dec, 40(4):449-458.
Sakai K. Physiological properties and afferent connections of the locus coeruleus and adjacent tegmental neurons involved in the generation of paradoxical sleep in the cat. Prog Brain Res (1991) 88: 31–45.
Schenck CH, Bundlie SR, Ettinger MG, Mahowald MW. Chronic Behavioral Disorders of Human REM Sleep: A New Category of Parasomnia. Sleep 1986; 9: 293–308.
Schenck CH, Boeve BF, Mahowald MW. Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series. Sleep Med 2013; 14: 744–748.
Seppi K, Ray Chaudhuri K, Coelho M, Fox SH, Katzenschlager R, Perez Lloret S, Weintraub D, Sampaio C. Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review. Mov Disord. 2019 Feb, 34(2):180-198.
Shamaila K, Fahad SK, Muhammad IMUR, Muhammad A, Muhammad R, Ghulam R, Abdul HK, Igra S, Saba S, Arif M. A review: Mechanism of action of antiviral drugs. International Journal of Immunopathology and Pharmacology. 2021, Feb 35: 1-12.
Stahl, SM. Stahl’s Essential Psychopharmacology. Neuroscientific Basis and Practical Applications. 2021, p. 213-220.
Swierczynska M, Mirowska-Guzel DM, Pindelska E. Review: Antiviral Drugs in Influenza. International Journal of Environmental Research and Public Health. 2012, Mar 19: 3018-3048.
Tourinho FS, Silva GVR, Bologna GTB, Almeida BCR, Andrade JPG, Toledo SL, Soares EA, Duarte GGM. A relação entre a privação do sono e a doença de alzheimer: uma revisão integrativa. Arquivos de Ciências da Saúde da UNIPAR. 2023. 27(5): 2745-2757, 2023
Zhang Y, Ren R, Sanford LD, Yang L, Zhou J, Tan L, Li T, Zhang J, Wing YK, Shi J, Lu L, Tang X. Sleep in Parkinson's disease: A systematic review and meta-analysis of polysomnographic findings. Sleep Med Rev. 2020 Jun 51:101281-X.
Zoetmulder M, Nikolic M, Biernat H, Korbo L, Friberg L, Jennum P. Increased Motor Activity During REM Sleep Is Linked with Dopamine Function in Idiopathic REM Sleep Behavior Disorder and Parkinson Disease. J Clin Sleep Med. 2016 Jun 15;12(6): 895-903.
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2023 Arquivos de Ciências da Saúde da UNIPAR
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Os Direitos Autorais para artigos publicados são de direito da revista. Em virtude da aparecerem nesta revista de acesso público, os artigos são de uso gratuito, com Creative Commons Attribution 4.0 International License.
A revista se reserva o direito de efetuar, nos originais, alterações de ordem normativa, ortográfica e gramatical, com vistas a manter o padrão culto da língua e a credibilidade do veículo. Respeitará, no entanto, o estilo de escrever dos autores.
Alterações, correções ou sugestões de ordem conceitual serão encaminhadas aos autores, quando necessário. Nesses casos, os artigos, depois de adequados, deverão ser submetidos a nova apreciação.
As opiniões emitidas pelos autores dos artigos são de sua exclusiva responsabilidade.
